COO

— Fundamental Stock Analysis and Report Card

Healthcare : Medical - Instruments & Supplies

Located in San Ramon, CA, US. The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

Growth

Revenue, earnings and profitability.

Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.

Revenue History

Earnings History

Margins

Gross Margin TTM
64.37%
EBITDA Margin TTM
20.47%
Net Margin TTM
5.57%
Earnings Per Share TTM
1.21
Statements

Income & Cash Flow analysis.

An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.

The Cooper Companies, Inc.
Select Period:
Q2 2026
Total ($)
Q2 2026
Margin (%)
Revenue
1.1b
+79.2m
+7.9%
Gross Income
735.4m
+56.3m
+8.3%
68%
+0.2pp
+0.4%
EBITDA
67.9m
-193.4m
-74.0%
6%
-19.8pp
-75.9%
Operating Income
-31.0m
-215.8m
-116.8%
-3%
-21.3pp
-115.5%
Net Income
-77.9m
-165.6m
-188.8%
-7%
-16.0pp
-182.3%
Earnings Per Share
-0.40
-0.8
-191.2%
Operating Cash Flow
182.8m
+86.6m
+90.0%
17%
+7.3pp
+76.1%
Free Cash Flow
96.4m
+78.3m
+432.6%
9%
+7.1pp
+393.6%
Research & Development
42.5m
-3.0m
-6.6%
4%
-0.6pp
-13.4%